Bumetanide and International normalised ratio increased - a phase IV clinical study of FDA data
Summary:
International normalised ratio increased is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Warfarin Sodium, and have Atrial fibrillation/flutter.
The phase IV clinical study analyzes which people have International normalised ratio increased when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.
What is Bumetanide?
Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.
What is International normalised ratio increased?
International normalised ratio increased is found to be associated with 1,340 drugs and 1,726 conditions by eHealthMe. Check the latest studies of International normalised ratio increased.
20,353 people reported to have side effects when taking Bumetanide.
Among them, 272 people (1.34%) have International normalised ratio increased.

Among these 272 people:
How long have people been on Bumetanide when they have International normalised ratio increased? *
What is the gender of people who have International normalised ratio increased when taking Bumetanide? *
What is the age of people who have International normalised ratio increased when taking Bumetanide? *
What are other drugs people take besides Bumetanide? *
What are other side effects people have besides International normalised ratio increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Bumetanide and have International normalised ratio increased?
- Check whether International normalised ratio increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Bumetanide:
- Bumetanide (20,532 reports)
International normalised ratio increased treatments and more:
- International normalised ratio increased (40,071 reports)
How severe was International normalised ratio increased and when was it recovered:
Expand to all the drugs that have ingredients of bumetanide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bumetanide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with International normalised ratio increased:
- International normalised ratio increased (1,340 drugs)
Browse all the conditions that are associated with International normalised ratio increased:
- International normalised ratio increased (1,726 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Keppra for Juvenile Myoclonic Epilepsy? - now
- Drowsiness in Topiramate, how severe and when it was recovered? - now
- Could Codeine cause Vena Cava Thrombosis? - 6 seconds ago
- Drug interactions of Penicillin and Actonel - 7 seconds ago
- Ovarian Cysts and Gingival Bleeding - 10 seconds ago
- Vyvanse vs. Dexmethylphenidate Hydrochloride, side effect and effectiveness comparison - 11 seconds ago
- Could Keppra cause Kidney Infection? - 13 seconds ago
- Drug interactions of Betamethasone Sodium Phosphate and Ramipril - 17 seconds ago
- Could Relpax cause Photophobia? - 17 seconds ago
- Could Carpine cause Temporomandibular Joint Syndrome? - 28 seconds ago